- Home
- COGT vs HSTM Comparison
COGT vs HSTM Comparison
Compare COGT & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- HSTM
- Stock Information
- Founded
- COGT 2014
- HSTM 1990
- Country
- COGT United States
- HSTM United States
- Employees
- COGT N/A
- HSTM 1092
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- HSTM Computer Software: Programming Data Processing
- Sector
- COGT Health Care
- HSTM Technology
- Exchange
- COGT Nasdaq
- HSTM Nasdaq
- Market Cap
- COGT 900.3M
- HSTM 977.5M
- IPO Year
- COGT 2018
- HSTM 2000
- Fundamental
- Price
- COGT $7.90
- HSTM $32.34
- Analyst Decision
- COGT Buy
- HSTM Hold
- Analyst Count
- COGT 6
- HSTM 2
- Target Price
- COGT $14.20
- HSTM $29.00
- AVG Volume (30 Days)
- COGT 1.7M
- HSTM 129.0K
- Earning Date
- COGT 11-12-2024
- HSTM 10-21-2024
- Dividend Yield
- COGT N/A
- HSTM 0.35%
- EPS Growth
- COGT N/A
- HSTM 52.12
- EPS
- COGT N/A
- HSTM 0.65
- Revenue
- COGT N/A
- HSTM $287,992,000.00
- Revenue This Year
- COGT N/A
- HSTM $6.35
- Revenue Next Year
- COGT N/A
- HSTM $5.23
- P/E Ratio
- COGT N/A
- HSTM $49.26
- Revenue Growth
- COGT N/A
- HSTM 3.96
- 52 Week Low
- COGT $4.28
- HSTM $23.92
- 52 Week High
- COGT $12.61
- HSTM $33.52
- Technical
- Relative Strength Index (RSI)
- COGT 32.81
- HSTM 50.57
- Support Level
- COGT $7.94
- HSTM $31.88
- Resistance Level
- COGT $8.56
- HSTM $32.72
- Average True Range (ATR)
- COGT 0.60
- HSTM 0.59
- MACD
- COGT -0.06
- HSTM -0.19
- Stochastic Oscillator
- COGT 9.60
- HSTM 14.79
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.